To investigate these questions, we used an immunoassay (Siemens Dimension RxL) to measure Hb A 1c in 2 unused RBC units stored in additive storage medium (AS-1) under standard blood bank conditions. These 2 units were unacceptable for transfusion because they had been out of the control of the blood bank for Ͼ30 min. The Hb A 1c values for samples obtained from the units on their expiration date (42 days after collection) were 5.4% (B Rh-positive) and 5.7% (O Rh-positive), which are within our reference interval (Ͻ6.0%). The glucose concentrations in the blood units at this time were 36.9 mmol/L (665 mg/ dL) and 32.5 mmol/L (586 mg/ dL), confirming the supraphysiological glucose content of the RBC storage medium. We observed minimal increases in Hb A 1c values in the units after additional incubation at room temperature for 9 days (5.7% and 5.9%) and at 37°C for another 14 days (6.0% and 6.0%). This finding strongly suggests that glycation of hemoglobin in stored RBC units is negligible despite the high glucose concentrations in stored RBC units.
To determine if RBC transfusion has a measurable effect on Hb A 1c in patients, we retrospectively queried an institutional review board-approved database of deidentified patient data from our hospital for patients who received RBC transfusions and had Hb A 1c measurements performed within 28 days before and 14 days after they received at least 1 RBC transfusion. We allowed a maximum of 7 days between the first and last transfusions for patients who received multiple transfusions; therefore, the maximum time between the pre-and posttransfusion Hb A 1c measurements was 49 days. Fig. 1 
